Nektar Therapeutics
NKTR
#5687
Rank
NZ$2.00 B
Marketcap
NZ$98.49
Share price
-1.37%
Change (1 day)
278.67%
Change (1 year)

Nektar Therapeutics (NKTR) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$0.37 Billion

According to Nektar Therapeutics 's latest financial reports the company's total liabilities are NZ$0.37 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Nektar Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$0.43 B2.08%
2023-12-31NZ$0.42 B-22.05%
2022-12-31NZ$0.54 B-15.45%
2021-12-31NZ$0.64 B0.19%
2020-12-31NZ$0.63 B-24.69%
2019-12-31NZ$0.84 B31.69%
2018-12-31NZ$0.64 B8.79%
2017-12-31NZ$0.59 B-14.58%
2016-12-31NZ$0.69 B-3.5%
2015-12-31NZ$0.71 B39.03%
2014-12-31NZ$0.51 B-18.95%
2013-12-31NZ$0.63 B16.46%
2012-12-31NZ$0.54 B4.63%
2011-12-31NZ$0.52 B-6.16%
2010-12-31NZ$0.55 B-14.33%
2009-12-31NZ$0.65 B2.07%
2008-12-31NZ$0.63 B-4.26%
2007-12-31NZ$0.66 B-13.2%
2006-12-31NZ$0.76 B-1.27%
2005-12-31NZ$0.77 B99.99%
2004-12-31NZ$0.38 B-44.13%
2003-12-31NZ$0.69 B-8.87%
2002-12-31NZ$0.76 B-20.07%
2001-12-31NZ$0.95 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
NZ$139.38 B 37,133.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$200.16 B 53,370.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$134.39 B 35,800.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
NZ$70.44 M-81.18%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$118.54 B 31,567.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
NZ$23.97 B 6,305.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ$1.03 B 175.63%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
NZ$196.53 B 52,400.91%๐Ÿ‡บ๐Ÿ‡ธ USA